Applications of Androst-4-Ene-3,6,17-Trione in Industrial Manufacturing

Androst-4-Ene-3,6,17-Trione plays an integral role in several specialized sectors where precise hormone modulation or intermediate synthesis defines process efficiency and final product performance. This page details its established applications across key industries, outlining standards, integration methods, and relevant end-product types to support informed industrial B2B usage.

1. Pharmaceutical Synthesis: Steroid Hormone Intermediates

In the pharmaceutical sector, this raw material serves as a core ketosteroid intermediate for the synthesis of corticosteroids, estrogen blockers, and certain anti-androgen drugs. Its standardized purity and crystalline structure facilitate consistent conversion rates in hydrogenation or reduction pathways. Manufacturers leverage it in regulated bulk API production under strict GMP conditions, often at scale, to meet global pharmacopoeia and market-access requirements.

Industry compliance standards

• ICH Q7, Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monograph 01/2019:2086
• 21 CFR Parts 210/211 (US FDA)
• Japanese Pharmacopoeia (JP) Standards

Typical usage ratio

• Employed at 5%–9% w/w as a starting intermediate for hormone analog synthesis; exact ratio refined based on molecular conversion efficiency and targeted yield within the specific steroid pathway.

Downstream process integration

• Added to the hormone synthesis vessel post-feedstock purification and prior to catalytic hydrogenation or reduction.
• Monitored via HPLC during intermediate step validation phase before further transformation to final API.

Final product types

• Bulk API for corticosteroids (e.g., prednisolone, methylprednisolone)
• Non-steroidal aromatase inhibitors
• Anti-estrogenic pharmaceuticals
• Pharmaceutical intermediates meeting USP/EP/JP specs

2. Veterinary Drug Manufacturing

Androst-4-Ene-3,6,17-Trione supports the development of regulated veterinary pharmaceuticals, including steroid-based therapeutics applied in livestock health management. Manufacturers in this arena depend on documented batch consistency and validated process controls to align with animal health authority directives and residue monitoring programs. This chemical’s reliable reactivity in modified steroid synthesis direct impacts product safety and withdrawal period compliance.

Industry compliance standards

• VICH GL2: Good Manufacturing Practice for Active Pharmaceutical Ingredients (Animals)
• European Medicines Agency (EMA) Veterinary Requirements
• US FDA CVM Guidance
• ISO 9001:2015 for animal-use APIs

Typical usage ratio

• Applied at 6%–10% of formulation mass during active ingredient manufacturing; adjusted to account for targeted residue profile in finished veterinary drugs.

Downstream process integration

• Introduced during the steroidal synthesis stage, following initial solvent extraction and purification.
• Subsequent chemical conversion to animal-use hormone analogues or anti-inflammatory actives via controlled batch reactors.

Final product types

• Livestock steroidal injectables
• Veterinary anti-inflammatory agents
• Oral and parenteral veterinary formulations
• Premix ingredients for regulated animal pharmaceuticals

3. Sports Nutrition Ingredient Production

This material is widely processed as an active ingredient within the sports supplement market, primarily in facilities registered for food-grade or nutritional ingredient manufacturing. Used for its aromatase inhibiting properties, downstream processors apply it under controls set by food additive regulations and verify batch-to-batch conformity using validated in-house assays. Compliance with regional market bans or restrictions is necessary, as human supplement standards can vary.

Industry compliance standards

• FDA 21 CFR 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements (US)
• EFSA Novel Food Regulation (EU)
• NSF/ANSI 173: Dietary Supplements Certification
• China Food Additive Standards GB 2760 (where allowed)

Typical usage ratio

• Integrated at 0.2%–0.5% per finished dosage unit; dosage refined to comply with local maximum allowed limits and analyzed for batch uniformity pre-release.

Downstream process integration

• Dosed during blending of encapsulated or compressed forms, following premixing with bulking agents and stabilizers.
• Subjected to dissolution testing and label claim validation prior to packaging.

Final product types

• Bodybuilding supplement capsules
• Sports tablets containing aromatase inhibitors
• Prohormone blend powders
• Regulated OTC sports nutrition products (country-dependent)

4. Fine Chemical Intermediate for Research & Diagnostics

Specialty chemical manufacturers incorporate Androst-4-Ene-3,6,17-Trione as a purified analytical or synthesis-quality reference in research institutions, clinical laboratories, and development of hormone quantification kits. The highly documented material specifications meet advanced QC requirements, allowing for accurate calibration and reproducible experimental results. All upstream and downstream handling follows local research-use only (RUO) guidelines and research chemical supply rules to prevent off-label application.

Industry compliance standards

• ISO 13485:2016 for research reagent manufacturing (where diagnostics are involved)
• OECD Principles of Good Laboratory Practice (GLP)
• REACH Annex XVII for restricted chemicals in EU R&D
• RUO (Research Use Only) labeling requirements

Typical usage ratio

• Used between 0.01%–0.2% w/v, determined according to specific application: analytical assay calibration, controlled synthesis, or as a traceable reference for LC/MS or ELISA kit development.

Downstream process integration

• Incorporated into solvent-based stocks or calibration standards during formulation of research reagents for in vitro testing.
• Delivered in precision-dosed vials, ready for integration into automated testing modules or manual bench protocols.

Final product types

• Analytical reference standards for clinical laboratories
• Research-use diagnostic kits
• Custom synthesis intermediates for biomedical R&D
• Hormone assay calibration solutions